Stevens Capital Management LP bought a new position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 6,428 shares of the company’s stock, valued at approximately $249,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of BBWI. Fifth Third Wealth Advisors LLC grew its holdings in shares of Bath & Body Works by 4.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock worth $271,000 after purchasing an additional 324 shares during the last quarter. SRS Capital Advisors Inc. grew its stake in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares in the last quarter. TD Private Client Wealth LLC increased its position in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after acquiring an additional 331 shares during the period. UMB Bank n.a. raised its stake in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its holdings in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after purchasing an additional 431 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.
Analyst Upgrades and Downgrades
BBWI has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. set a $47.00 price objective on Bath & Body Works in a report on Thursday, February 27th. TD Cowen raised their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Raymond James reaffirmed an “outperform” rating and issued a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a research report on Tuesday, February 25th. Finally, Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $42.00 to $48.00 in a report on Friday, January 10th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $45.06.
Bath & Body Works Trading Up 7.2 %
NYSE:BBWI opened at $32.47 on Tuesday. Bath & Body Works, Inc. has a twelve month low of $26.21 and a twelve month high of $52.99. The company has a market cap of $6.96 billion, a PE ratio of 7.92, a P/E/G ratio of 0.92 and a beta of 1.89. The company’s 50 day moving average is $35.62 and its two-hundred day moving average is $34.01.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s dividend payout ratio is presently 21.98%.
Bath & Body Works announced that its board has authorized a share buyback program on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Five stocks we like better than Bath & Body Works
- The Role Economic Reports Play in a Successful Investment Strategy
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Canadian Penny Stocks: Can They Make You Rich?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.